CGON•benzinga•
Morgan Stanley Assumes CG Oncology at Overweight, Maintains Price Target of $55
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 7, 2025 by benzinga